A CRITIQUE ON THE EVALUATION AND MODE OF ACTION OF ANTIESTROGENSSANKARAN MS; PRASAD MRN.1972; GYNECOL. INVEST.; SWITZ.; DA. 1972; VOL. 3; NO 1-4; PP. 142-147; BIBL. 1 P.Article

Effect of toremifene on estrogen primed vaginal mucosa in postmenopausal womenMAÊENPAÊAÊ, J; SOÊDERSTROÊM, K.-O; GROÊNROOS, M et al.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 221-223, issn 0022-4731, 3 p.Conference Paper

Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers : phase I studyKIVINEN, S; MAENPAÊAÊ, J.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 217-220, issn 0022-4731, 4 p.Conference Paper

Effects of a new antiestrogen, keoxifene (LY 156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levelsCLEMENS, J. A; BENNETT, D. R; BLACK, L. J et al.Life sciences (1973). 1983, Vol 32, Num 25, pp 2869-2875, issn 0024-3205Article

Purification a homogénéité du site de liaison des antioestrogènes (ABS); évaluation des rôles respectifs d'ABS et du récepteur des oestrogènes dans l'activité antiréplicative du tamoxifène = Purification to homogeneity of the antioestrogen binding site (ABS); evaluation of the respective roles of ABS and of the oestrogen receptor in the antireplicative activity of tamoxifenChailleux, Catherine; Bayard, Francis.1992, 153 p.Thesis

ANTITUMOR ACTIVITIES AND ESTROGEN RECEPTOR INTERACTIONS OF THE METABOLITES OF THE ANTIESTROGENS C1628 AND U23, 469 IN THE 7,12-DIMETHYLBENZ (A) ANTHRACENE-INDUCED RAT MAMMARY TUMOR SYSTEMRORKE EA; KATZENELLENBOGEN BS.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 4; PP. 1257-1262; BIBL. 37 REF.Article

ACTION OF AN ESTROGEN ANTAGONIST IN INTACT AND OVARIECTOMIZED RATSPERRY K; DIPASQUALE G; FERGUSON E et al.1973; CONTRACEPTION; U.S.A.; DA. 1973; VOL. 7; NO 3; PP. 231-242; BIBL. 2P.1/2Article

Additive and synergistic antitumor effects with toremifene and interferonsKANGAS, L; CANTELL, K; SCHELLEKENS, H et al.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 259-262, issn 0022-4731, 4 p.Conference Paper

Design of novel antiestrogensHENDRY, L. B; CHU, C. K; ROSSER, M. L et al.Journal of steroid biochemistry and molecular biology. 1994, Vol 49, Num 4-6, pp 269-280, issn 0960-0760Conference Paper

La contraception par les progestatifs normodosés = Contraception using nomodose progestinsPELISSIER-LANGBORT, C.Contraception fertilité sexualité (1973). 1984, Vol 12, Num 10, pp 1099-1109, issn 0301-861XArticle

Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cellsSCHNEIDER, J; HUH, M. M; BRADLOW, H. L et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 8, pp 4840-4845, issn 0021-9258Article

Review of the pharmacological properties of toremifeneKANGAS, L.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 191-195, issn 0022-4731, 5 p.Conference Paper

Nonendocrine pathways and endocrine resistance: Observations with antiestrogens and signal transduction inhibitors in combinationNICHOLSON, Robert I; HUTCHESON, Iain R; KNOWLDEN, Janice M et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 346s-354s, issn 1078-0432, 2Conference Paper

An evaluation of tamoxifen as a partial agonist by classical receptor theory ― an explanation of the dual action of tamoxifenMACNAB, M. W; TALLARIDA, R. J; JOSEPH, R et al.European journal of pharmacology. 1984, Vol 103, Num 3-4, pp 321-326, issn 0014-2999Article

Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitroJORDAN, V. C; LIEBERMAN, M. E; CORMIER, E et al.Molecular pharmacology. 1984, Vol 26, Num 2, pp 272-278, issn 0026-895XArticle

1-Carbamoylalkyl-2-phenylindoles : relationship between side chain structure and estrogen antagonismVON ANGERER, E; BIBERGER, C; HOLLER, E et al.Journal of steroid biochemistry and molecular biology. 1994, Vol 49, Num 1, pp 51-62, issn 0960-0760Article

Distribution and excretion pattern of ¹⁴C-labelled centchroman in the rhesus monkey (Macaca mulatta)MISHRA, N. C; RATNA, S; RAY, S et al.Medical science research. 1992, Vol 20, Num 7, pp 259-260, issn 0269-8951Article

The role of endocrine therapy in primary breast cancerBAUM, M.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 187-189, issn 0022-4731, 3 p.Conference Paper

Structural studies on some tamoxifen derivativesKURODA, R; CUTBUSH, S; NEIDLE, S et al.Journal of medicinal chemistry (Print). 1985, Vol 28, Num 10, pp 1497-1503, issn 0022-2623Article

The oestrogen antagonists, tamoxifen and FC-1157a, display oestrogen like effects on human lymphocyte functions in vitroPAAVONEN, T; ANDERSSON, L. C.Clinical and experimental immunology (Print). 1985, Vol 61, Num 2, pp 467-474, issn 0009-9104Article

Mécanisme d'action des antioestrogènes: interaction avec les systèmes régulateurs de l'AMPc = Mechanism of action of antoestrogens: Interaction with cyclic AMP regulatory systemsFanidi, Abdallah; Laugier, Christian.1990, 392 p.Thesis

SUPPRESSION OF LACTATION BY AN ANTIESTROGEN, TAMOXIFENSHAABAN MM.1975; EUROP. J. OBSTETR. GYNECOL. REPROD. BIOL.; NETHERL.; DA. 1975; VOL. 4; NO 5; PP. 167-169; BIBL. 9REF.Article

THE EFFECT OF ANTIESTROGENS ON THE NUCLEAR BINDING OF THE ESTROGEN RECEPTOR = EFFET DES ANTIOESTROGENES SUR LA LIAISON NUCLEAIRE DU RECEPTEUR OESTROGENIQUERUH TS; RUH MF.1974; STEROIDS; U.S.A.; DA. 1974; VOL. 24; NO 2; PP. 209-224; BIBL. 1P.1/2Article

L'EFFET ANTIOESTROGENESJAMIN C; GAYRAUD M; HAZARD J et al.1982; SEM. HOP.; ISSN 0037-1777; FRA; DA. 1982; VOL. 58; NO 32; PP. 1793-1799; ABS. ENG; BIBL. 25 REF.Article

SYNTHESIS AND ANTIESTROGENIC ACTIVITY OF 2,4-BIS (BROMOMETHYL)-ESTRONE METHYL ETHER: A BIFUNCTIONAL ALKYLATING STEROID = SYNTHESE ET ACTIVITE ANTI-OESTROGENIQUE DU 2,4-BIS (BROMOMETHYL)-OESTRONE METHYL ETHER: STEROIDE ALKYLANT BIFONCTIONNELNARASHIMHA RAO KANAMARLAPUDI; SWEET F; WARREN JC et al.1974; STEROIDS; U.S.A.; DA. 1974; VOL. 24; NO 1; PP. 63-77; BIBL. 13REF.Article